Skip to main content
Premium Trial:

Request an Annual Quote

Illumina s Q3 Revenues Jump 44 Percent, Losses Narrow

NEW YORK, Oct. 24 (GenomeWeb News) - Illumina today reported a 44-percent increase in third-quarter revenues accompanied by narrowed net losses.

 

The company posted total revenues of $19.5 million for the quarter ended Oct. 2, up from $13.5 million in the third quarter of 2004. Product-related revenues jumped to $16.3 million from $12.1 million in the prior-year period, while service revenues increased to $2.7 million from $1.1 million in the comparable period of 2004.

 

Illumina credited the increase in revenues to a "record" 19 BeadStations shipped during the quarter, bringing the company's installed base of Beadlabs and BeadStations to 102.

 

IIllumina narrowed its quarterly net loss to $1.4 million, or $.03 per share, from $2 million, or $.05 per share, in the third quarter of 2004.

 

The company increased its third-quarter R&D spending to $7.1 million from $5.4 million in the prior-year period.

 

Illumina held cash and investments totaling $50.2 million as of Oct. 2.

 

Looking forward, the company projected revenues of between $21 million and 23 million for the fourth quarter of its fiscal year - up to 55 percent over fourth-quarter 2004 revenues of $14.8 million.

 

For the full year, Illumina said it expects total revenues of between $72 million and $74 million, which would represent an increase of up to 46 percent over $50.6 million in 2004 revenues. 

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.